Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases-Reference-Cited by-同舟云学术

Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases

Published:2022-05-05 Issue:9 Volume:107 Page:2232-2237
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Fang Hong,Wang Sa A.,Khoury Joseph D.,El Hussein Siba,Kim Do Hwan,Tashakori Mehrnoosh,Tang Zhenya,Li Shaoying,Hu Zhihong,Jelloul Fatima Zahra,Patel Keyur P.,McDonnell Timothy J.,Kadia Tapan,Medeiros L. Jeffrey,Wang Wei

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference15 articles.

1. Pure erythroid leukemia

2. De novo pure erythroid leukemia: refining the clinicopathologic and cytogenetic characteristics of a rare entity

3. Acute Erythroleukemias, Acute Megakaryoblastic Leukemias, and Reactive Mimics

4. Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification

5. More than 1 TP53 abnormality is a dominant characteristic of pure erythroid leukemia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Erythroid Leukemia Post-Chemo-Radiotherapy and Autologous Stem Cell Transplantation Due to Multiple Myeloma: Tracing the Paths to Leukemic Transformation;International Journal of Molecular Sciences;2024-07-22

2. Acute Erythroid Leukemia: From Molecular Biology to Clinical Outcomes;International Journal of Molecular Sciences;2024-06-06

3. Immunohistochemistry screening for TP53 mutation in myeloid neoplasms in AZF-fixed bone marrow biopsies;Pathology;2024-04

4. Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach;Leukemia & Lymphoma;2024-03-27

5. Survival after Pure (Acute) Erythroid Leukemia in the United States: A SEER-Based Study;Cancers;2023-08-03